¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Zinc Amino Acid Misc"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
¿µ¹® nucleic acid ÇÑ±Û ÇÙ»ê
¼³¸í   
  ¿°±â, ´ç, ÀλêÀ¸·Î ÀÌ·ç¾îÁø ´ºÅ¬·¹¿ÀƼµå°¡ ±ä »ç½½ ¸ð¾çÀ¸·Î ÁßÇյȠ°íºÐÀÚ ¹°Áú. À¯ÀüÀ̳ª ´Ü¹éÁú ÇÕ¼ºÀ» Áö¹èÇϴ Áß¿äÇÑ ¹°Áú·Î, »ý¹°ÀÇ Áõ½ÄÀ» ºñ·ÔÇÑ »ý¸í È°µ¿ À¯Áö¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù. ±¸¼º ´çÀΠ¿Àź´çÀÌ ¸®º¸¿À½ºÀΠ¸®º¸ÇÙ»ê°ú µð¿Á½Ã¸®º¸¿À½ºÀΠµð¿Á½Ã¸®º¸ ÇÙ»êÀ¸·Î ³ª´¶´Ù. ÆæÅ佺·Î¼­ ¸®º¸½º³ª µ¥¿Á½Ã¸®º¸½º ¾î´À ÇÑÂʸ¸À» Æ÷ÇÔÇϸç ÀüÀÚ¸¦ ¸®º¸ÇÙ»ê(RNA), ÈÄÀÚ¸¦ µ¥¿Á½Ã¸®º¸ÇÙ»ê(deoxyribonucleic acid, DNA)À̶ó ºÎ¸¥´Ù. ¸ðµÎ 4Á¾·ùÀÇ À¯±â¿°±â¿¡ ÀÇÇØ Æ¯Â¡Áö¾îÁö¸ç ¾Æµ¥´Ñ, ±¸¾Æ´Ñ ¹× ½ÃÅä½ÅÀº ¾çÀÚ¿¡ °øÅëÀÌ´Ù. Æ¼¹ÎÀº DNA¿¡, ¿ì¶ó½ÇÀº RNA¿¡ Æ÷ÇԵȴÙ. DNA´Â ÁַΠÇÙ¿¡ Á¸ÀçÇϸç ÇüÁúÀ¯Àü¿¡ ±×¸®°í RNA´Â ¼¼Æ÷Áú¼Ó¿¡¼­ ´Ü¹éÁú ÇÕ¼º¿¡ °ü¿©ÇÑ´Ù. ¼·ÃëµÈ ÇÙ»êÀº ¼ÒÈ­°ü¿¡¼­ ±¸¼ººÐÀڷαîÁö °¡¼öºÐÇØµÇ¾î Èí¼öµÈ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • acid lipase
    »ê¼ºÁöÁúºÐÇØÈ¿¼Ò
  • acid maltase
    »ê¼º¸»Å¸¾ÆÁ¦
  • acid mucopolysaccharide
    »ê¼ºÁ¡¾×´Ù´ç·ù, »ê¼º¹ÂÄÚ´Ù´ç·ù
  • acid phosphatase
    »ê¼ºÀλêºÐÇØÈ¿¼Ò
  • acid pyuria
    »ê¼º°í¸§´¢, »ê¼º³ó´¢
  • acid radical
    »ê±â, »ê¶óµðÄ®
  • acid rain
    »ê¼ººñ
  • acid salt
    »ê¿°
  • acid therapy
    »ê¿ä¹ý
  • acid-base compensation
    »ê¿°±âº¸»ó
  • acid-base equilibrium
    »ê¿°±âÆòÇü
  • acid-base indicator
    »ê¿°±âÁö½Ã°è
  • acid-fast
    Ç×»ê-
  • acid-fast bacillus
    Ç׻긷´ë±Õ, Ç×»ê±Õ
  • acid-fast bacterium
    Ç×»ê±Õ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • sulfuric acid
    Ȳ»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • uric acid
    ¿ä»ê
  • valproic acid
    ¹ßÇÁ·ÎÀÌÅ©»ê
  • vanillylmandelic acid
    ¹Ù´Ò¸¸µ¨»ê
  • gamma aminobutyric acid
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê
  • acid burn
    »êÈ­»ó
  • acid-fast bacterium
    Ç×»ê±Õ
  • acid-fast bacillus
    Ç׻긷´ë±Õ, Ç×»ê±Õ
  • uric acid nephropathy
    (¢¡ urate nephropathy) ¿ä»ê¿°ÄáÆÏº´Áõ
  • acid fast organism
    Ç×»ê±Õ
  • acid radical
    »ê±â
  • acid salt
    »ê¼º¿°
  • acid-fast stain
    Ç׻꿰»ö
  • acetylsalycylic acid antiplatelet therapy
    Ç×Ç÷¼ÒÆÇ¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • acid fast organism
    Ç×»ê±Õ
  • acid lipase deficiency
    »ê¼ºÁöÁúºÐÇØÈ¿¼Ò°áÇÌ
  • acid-base compensation
    »ê¿°±âº¸»ó
  • acid-base equilibrium
    »ê¿°±âÆòÇü
  • acid-base indicator
    »ê¿°±âÇ¥Áö½Ã°è
  • acid-fast bacillus
    Ç׻긷´ë±Õ, Ç×»ê±Õ
  • acid-fast bacterium
    Ç×»ê±Õ
  • acid-fast stain
    Ç׻꿰»ö
  • allokainic acid
    ¾Ë·ÎÄ«Àλê
  • aminohippuric acid
    ¾Æ¹Ì³ë¸¶´¢»ê
  • anthranilic acid
    ¾ÈÆ®¶ó´Ò»ê
  • arachidonic acid
    ¾Æ¶ó۵·»ê
  • arsenic acid
    ºñ»ê
  • ascorbic acid
    ¾Æ½ºÄÚ¸£ºó»ê
  • benzoic acid
    º¥Á¶»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Deoxycholic acid
    µð¿Á½ÃÄݸ¯»ê
  • Deoxyribonucleic acid
    µð¿Á½Ã¸®º¸´ºÅ¬·¹ÀÍ»ê
  • FA fatty acid
    Áö¹æ»ê.
  • FFA= free fatty acid
    À¯¸®Áö¹æ»ê.
  • Fatty acid
    Áö¹æ»ê(ò·Û¸ß«)
  • Fatty acid-CoA
    Áö¹æ»ê(ò·Û¸ß«) ÄÚ¿£ÀÚÀÓA
  • Folic acid
    ¿±»ê(ç¨ß«)
  • GABA=> gamma aminobutyric acid
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê.
  • GABA=£¾gamma aminobutylic acid
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê.
  • GABA=£¾gamma aminobutylic acid
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê(ß«).
  • Gamma-aminobutyric acid
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê(ß«)
  • Glycogen-lactic acid system
    ±Û¸®ÄÚ°Õ-¶ôÆ®»ê°è
  • Growth folic acid in
    ¼ºÀå(à÷íþ)¿°»ê(ç¤ß«)¿°
  • HIAA = 5-hydroxyindoleacetic acid
    5-ÇÏÀ̵å·ÎÀε¹ÃÊ»ê
  • Hydrochloric acid
    ÇÏÀ̵å·ÎÅ©·Ð»ê
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • protamin(e) zinc insulin
    ÇÁ·ÎŸ¹Î¾Æ¿¬ Àν¶¸°.
  • stomatitis, zinc
    ¾Æ¿¬(¼º) ±¸³»¿°
  • zinc
    ¾Æ¿¬
  • zinc
    ¾Æ¿¬
  • zinc alloy
    ¾Æ¿¬ÇÕ±Ý(䬿çùêÐÝ).
  • zinc carbonate
    ¼®Åº»ê¾Æ¿¬(à´÷©ß«ä¬æç).
  • zinc caustic
    ¾Æ¿¬ºÎ½ÄÁ¦(¡­Ý¯ãÚð¥).
  • zinc colic
    ¾Æ¿¬»êÅë(¡­ß¨÷Ô).
  • zinc colic
    ¾Æ¿¬»êÅë(¡­ß¨÷Ô)
  • zinc copper cell
    ¾Æ¿¬±¸¸®ÀüÁö(¡­ï³ò®).
  • zinc dust
    ¾Æ¿¬Áø.
  • zinc glucagon
    ¾Æ¿¬±Û·çÄ«°ï.
  • zinc insulin crystals
    ¾Æ¿¬Àν¶¸°°áÁ¤(¡­Ì¿ïÜ).
  • zinc ointment
    ¾Æ¿¬È­¿¬°í(¾Æ¿¬È­¿¬°í).
  • zinc ointment
    ¾Æ¿¬È­ ¿¬°í.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • CBZ-amino acid
    (å²) carbobenzoxy-¾Æ¹Ì³ë»ê(ß«)
  • cell-free amino acid incorporating system
    ¹«¼¼Æ÷(Ùíá¬øà) ¾Æ¹Ì³ë»ê ÆíÀÔ(øºìý)¾¾½ºÅÛ
  • charged polar amino acid
    ±Ø¼º(пàü) ¾Æ¹Ì³ë»ê(ß«)
  • conservative amino acid replacement
    "º¸Á¸¼º(ÜÁðíàõ) ¾Æ¹Ì³ë»ê ´ëÄ¡(ÓÛöÇ), (ÔÒ) conservative substitution"
  • dansyl amino acid
    ´í½Ç ¾Æ¹Ì³ë»ê(ß«)
  • dinitrophenyl amino acid
    ÀÌ(ì£)´ÏÆ®·ÎÆä´Ò ¾Æ¹Ì³ë»ê(ß«)
  • dispensable amino acid
    "ºñÇʼö(Þªù±âÎ) ¾Æ¹Ì³ë»ê(ß«), °¡°á(ʦÌÀ)¾Æ¹Ì³ë»ê(ß«), (ÔÒ) nonessential amino acid"
  • DNP-amino acid
    DNP-¾Æ¹Ì³ë»ê(ß«) (ÔÒ) dinitrophenyl amino acid
  • Dns-amino acid
    Dns-¾Æ¹Ì³ë»ê(ß«) (ÔÒ) dansyl amino acid
  • essential amino acid
    Çʼö(ù±âÎ) ¾Æ¹Ì³ë»ê(ß«)
  • essential amino acid index
    Çʼö(ù±âÎ) ¾Æ¹Ì³ë»ê(ß«) Áö¼ö(ò¦â¦)
  • glucoplastic amino acid
    ±Û·çÄÚ½º»ý¼º(ßæà÷) ¾Æ¹Ì³ë»ê(ß«)
  • glycogenic amino acid
    ±Û¶óÀÌÄÚÀü »ý¼º(ßæà÷)¾Æ¹Ì³ë»ê(ß«)
  • helix-breaking amino acid
    ³ª¼±(Õ¢àÁ) ±ú±â ¾Æ¹Ì³ë»ê(ß«)
  • homocodonic amino acid
    ±Õ(г)ÄÚµ· ¾Æ¹Ì³ë»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PAA partial agonist activity; phenylacetic acid; phosphonoacetic acid; physical abilities analysis; plas...
AA   1) Aortic Arch(= Arcus Aortae)(= AA); ´ëµ¿¸Æ±Ã
  2) Aplastic Anemia - Anemia
ABA Amino-Butyric Acid
BCAA Branched Chain Amino Acid
¥â-ABA ¥â-Amino-Butyric Acid
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ZF Zinc finger
ZFP Zinc finger proteins
ZIO Zinc iodide-osmium tetroxide
ZOE Zinc oxide eugenol
ZnPc Zinc phthalocyanine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • zinc sulfate
    Ȳ»ê ¾Æ¿¬
    ¹«»ö, Åõ¸íÇÑ °áÁ¤Ã¼, ZnSO
  • zinc sulfate flotation procedure
    Ȳ»ê ¾Æ¿¬ ºÎ¾ç¹ý
  • 5-hydroxyindoleacetic acid
    5-ÇÏÀ̵å·Ï½Ã Àε¹ ¾Æ¼¼Æ½ ¿¡½Ãµå
    5-HT ´ë»ç »ê¹°ÀÇ ÇϳªÀÌ´Ù. ¾Ç¼º Á¾¾ç, ¹Ù³ª³ª ¼·Ãë ¹× reser
  • abietolic acid
    ¾Æºñ¿¡Åç»ê
    C20H28O7. °áÁ¤¼º »ê¼º ¼öÁö.
  • acetic acid solution
    ¾Æ¼¼Æ® »ê ¿ë¾×
  • acetoacetic acid test
    ¾Æ¼¼Åä ÃÊ»ê ½ÃÇè
  • acetrizoic acid
    ¾Æ¼¼Æ®¶óÀÌÁ¶»ê
    ¹«ÃëÀÇ ¹é»ö ºÐ¸».
  • acid
    Żȸ¾×
  • acid alcohol
    »ê¼º ¾ËÄÚ¿Ã
  • acid aspiration syndrome
    À§»ê ÈíÀÔ ÁõÈıº
  • acid bath
    »ê¿å
  • acid catalyser
    »ê Ã˸Å
  • acid decalcification theory
    Żȸ¼³
    ¿ì½ÄÀÇ º´Àο¡ °üÇÑ ¼³·Î ¼¼±ÕÀ» »ý»êÇÏ´Â »ê ȤÀº ´çºÐÀ» Æ÷ÇÔÇÑ À½½Ä¹°ÀÇ Àܻ翡 ¹ßÈ¿¿¡ ÀÇÇÏ¿© »ý±ä »êÀÌ Ä¡ÁúÀ» ŻȸÇÏ¿© ¿ì½ÄÀÌ »ý±ä´Ù´Â ¼³.
  • acid elution test
    »ê ¿ë¸® ½ÃÇè
    ÅÂ¾Æ Çì¸ð±Û·ÎºóÀÇ °ËÃâ ½ÃÇèÀ¸·Î, ½½¶óÀÌµå ±Û¶ó½º À§¿¡ °ø±â °ÇÁ¶µÈ Ç÷¾× µµÆ÷ Ç¥º»À» 80% ¸ÞŸ³î·Î °íÁ¤ÇÏ¿©,
  • acid etching
    »ê ºÎ½Ä
    »êÀ¸·Î ºÎ½Ä½ÃŰ´Â °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
sequence homology, amino acid The degree of similarity between sequences of amino acids. This information is useful for the understanding of genetic relatedness of certain species.
(12 Dec 1998)
N-(5-amino-1-ribosyl-4-imidazolylcarbonyl)-L-aspartic acid 5'-phosphate synthetase <enzyme> 5-amino-1-ribosyl-4-imidazole carboxylic acid 5'-phosphate (carboxy-air), ATP and aspartate yield n(5-amino-4-imidazolylcarbonyl)-l-aspartic acid 5'-phosphate(succino-aicar), ADP and p
Registry number: EC 6.3.4.-
(26 Jun 1999)
N(6)-(6-carbamoylhexyl)-FAD-D-amino acid oxidase <enzyme> A semi-synthetic oxidase; prepared by reacting the succinimido ester of n(6)-(6-carboxyhexyl)-fad with apo-d-amino acid oxidase from pig kidney in the presence of the benzoate
Registry number: EC 1.4.3.-
Synonym: nch-fad-daao
(26 Jun 1999)
N-carbamoyl-D-amino acid amidohydrolase <enzyme> From comamonas sp.e222c; mw 120 kD; hydrolyzes d-enantiomers of various n-carbamoyl-d-amino acids to d-amino acids, ammonia and co2; sensitive to thiol reagents; does not require metal ions
Registry number: EC 3.5.1.-
Synonym: caa-amidohydrolase, carbamoyl d-aa amidohyrolase
(26 Jun 1999)
nonessential amino acid <biochemistry> The amino acid's that can be synthesised by an organism and are thus not required in the diet.
(05 Mar 2000)
nonpolar amino acid An alpha-amino acid in which the functional group attached to the alpha-carbon (i.e., R in RCH(NH2)COOH) has hydrophobic properties; e.g., valine, leucine, alpha-aminobutyrate.
(05 Mar 2000)
D-amino acid malonyltransferase <enzyme> From mung beans
Registry number: EC 2.3.1.-
Synonym: 1-aminocyclopropanecarboxylate malonyltransferase, d-acc-malonyltransferase, acc n-malonyltransferase
(26 Jun 1999)
d-amino-acid oxidase <enzyme> Chemical name: D-Amino-acid:oxygen oxidoreductase (deaminating)
Registry number: EC 1.4.3.3
(12 Dec 1998)
D-amino acid transaminase <enzyme> Catalyses the alpha,beta elimination of the (d)-isomer of beta-chloroalanine or other amino acids to yield pyruvate, chloride and ammonia
Registry number: EC 2.6.1.-
(26 Jun 1999)
D-amino acid transferase <enzyme> Mw 41 kD; catalyses d-amino acid transfer; d-configuration specific; recognises aromatic d-amino acid esters to form oligo d-amino acid esters
Registry number: EC 2.3.2.-
(26 Jun 1999)
dibasic amino acid An amino acid containing a second basic group (usually an amino group); e.g., lysine, arginine, ornithine.
Synonym: dibasic amino acid.
(05 Mar 2000)
essential amino acid <biochemistry> Those amino acids that cannot be synthesised by an organism and must therefore be present in the diet. The term is often applied anthropocentrically to those amino acids required by humans (Ileu, Leu, Lys, Met, Phe, Thr, Try, & Val), though rats need two more (Arg & His).
(18 Nov 1997)
excitatory amino acid <biochemistry> The naturally occurring amino acids L glutamate and L aspartate and their synthetic analogues, notably kainate, quisqualate and NMDA. They have the properties of excitatory neurotransmitters in the CNS, may be involved in long-term potentiation and can act as excitotoxins.
at least three classes of EAA receptor have been identified, the agonists of the N type receptor are L aspartate, NMDA and ibotenate, the agonists of the Q type receptor are L glutamate and quisqualate, agonists of the K type are L glutamate and kainate. All three receptor types are found widely in the CNS and particularly the telencephalon, N and Q type receptors tend to occur together and may interact, their distribution is complementary to the K type receptors. The ion fluxes through the Q and K receptors are relatively brief, whereas the flux through the N type is longer and carries a significant amount of calcium. Additionally the N type receptor is blockaded by magnesium near the resting potential and thus shows voltage gated ion channel properties, leading to a regenerative response, this is why N type receptors have been linked to long-term potentiation.
Invertebrate glutamate receptors may not have the same properties as those described above.
(18 Nov 1997)
excitatory amino acid agents Drugs used for their actions on any aspect of excitatory amino acid neurotransmitter systems. Included are drugs that act on excitatory amino acid receptors, affect the life cycle of excitatory amino acid transmitters, or affect the survival of neurons using excitatory amino acids.
(12 Dec 1998)
excitatory amino acid agonists Drugs that bind to and activate excitatory amino acid receptors.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • dichlorophenlxyacetic acid
    (È­)µðŬ·Î·ÎÆä³ì½Ã¾Æ¼¼Æ®»ê(±× ³ªÆ®·ý¿°Àº Á¦ÃÊÁ¦)
  • ethacrynic acid
    (¾à)¿¡Å¸Å©¸°»ê
  • fatty acid
    Áö¹æ»ê
  • folic acid
    ¿±»ê(ºóÇ÷ÀÇ Æ¯È¿Á¦)
  • formic acid
    Æ÷¸§»ê
  • fulminic acid
    ³ú»ê
  • fumaric acid
    Ǫ¸¶¸£»ê
  • gallic acid
    °¥»ê
  • glacial acetic acid
    ºùÃÊ»ê
  • glutamic acid
    ±Û·çŸ¹Î»ê
  • hyaluronic acid
    È÷¾Ë·ç·Ð»ê (»ê¼º´ç·ù)
  • hydriodic acid
    ¿ÁÈ­ ¼ö¼Ò»ê
  • hydrochloric acid
    ¿°»ê
  • hydrocyanic acid
    ½Ã¾ÈÈ­ ¼ö¼Ò»ê;û»ê
  • hydrofluoric acid
    ºÒÈ­ ¼ö¼Ò»ê
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á